Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) EV to CFO (2011 - 2026)

Analysis

Abeona Therapeutics (ABEO) EV to CFO (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.82
Mar 31, 2026 -4.37
Dec 31, 2025 -5.50
Sep 30, 2025 -3.27
Jun 30, 2025 -3.49
Mar 31, 2025 -8.09
Dec 31, 2024 -9.43
Sep 30, 2024 -13.43
Jun 30, 2024 -4.23
Mar 31, 2024 -9.43
Dec 31, 2023 -5.91
Sep 30, 2023 -8.69
Jun 30, 2023 -4.81
Mar 31, 2023 -0.84
Dec 31, 2022 2.02
Sep 30, 2022 0.03
Jun 30, 2022 -0.54
Mar 31, 2022 -83.25
Dec 31, 2021 -25.97
Sep 30, 2021 -269.43